Dare Bioscience Inc. - DARE Forward P/S Multiple

Daré Bioscience, Inc. (DARE) - corporate logo

Dare Bioscience, Inc. (DARE), led by experienced top executives, ensures transparency across all clinical stages. The expected P/S ratio helps value future revenues, while the 9.30 metric determines this level. The company develops patented long-term women's health treatments, establishing a protected niche. The scaling strategy for its innovative gel is being implemented through global partnerships with pharmaceutical behemoths.

DARE darebioscience.com: Forward Price to Sales in the range 08/14/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Daré Bioscience, Inc. (DARE)

- current price and projected stock value:
Stock Price Daré Bioscience|DARE - Broker Consensus Forecast
- issuer market value details:
Market Capitalization Daré Bioscience, Inc.|DARE - Enterprise Value
- issuer book value statistics:
Net Assets per Single Share Daré Bioscience|DARE - Accounting Value of Company|Market Capitalization to Book Value Ratio darebioscience.com|DARE - Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Dare Bioscience, Inc.|DARE - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Dare Bioscience, Inc.|DARE - Company Debts|Debts to Book Capitalization Daré Bioscience, Inc.|DARE - Long-Term Debt Volume|Company Short-Term Debt Daré Bioscience|Quick Liquidity darebioscience.com
- business earnings and investment ratios data:
DARE - Net Financial Result|Projected Future Earnings Dare Bioscience, Inc.|DARE - Price to Earnings Ratio|Forward P/E Multiple Dare Bioscience Inc.|DARE - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Daré Bioscience, Inc.|DARE - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Daré Bioscience|DARE - Earnings per share for the last 12 months|Quarterly EPS earnings growth darebioscience.com|DARE - Net earnings per share growth this year|Earnings growth forecast for next year Dare Bioscience, Inc.
- company sales and revenue statistics:
DARE - Company Total Revenue|Company Future Sales Volume Daré Bioscience|DARE - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Daré Bioscience, Inc.
Summary company analytics:Daré Bioscience DARE
Manufactured products of Daré Bioscience, Inc.

The forward P/S ratio correlates the current market value of Dare Bioscience, Inc. (DARE) with projected annual sales, determining the premium the market is willing to pay for future cash flows. By analyzing the expected P/S value, an investor assesses the efficiency of the robotization of pharmaceutical development, as automated testing accelerates time-to-market, directly impacting future revenue dynamics and the ultimate business valuation.

Analysis of competing companies

Forward P/S Multiple OGN (Organon)|TXMD: Market Cap to Projected Revenue|Palatin - Forward P/S Multiple